Ben Bronstein
Directeur/Membre du Conseil chez ALDEYRA THERAPEUTICS, INC.
Fortune : 111 297 $ au 30/04/2024
Provenance du réseau au premier degré de Ben Bronstein
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 21 | |
Peptimmune, Inc.
 Peptimmune, Inc. BiotechnologyHealth Technology Peptimmune was founded in 2002 with technology from the laboratories of Dr. Jack Strominger, Higgins Professor of Biochemistry at Harvard University; and Dr. Hidde Ploegh, from the Whitehead Institute for Biomedical Research. Peptimmune has therapeutics in clinical development for the treatment of multiple sclerosis. Peptimmune's flagship program in multiple sclerosis features PI-2301, which has the opportunity to replace Copaxone® (Teva Pharmaceuticals), the world's leading first-line therapy for the treatment of MS. Peptimmune has broad expertise in MHC Class II molecules and their role in antigen presentation and modulation of immune responses. The Company exploits its proprietary DEEP Technology (Directed Expansion of Epitope Permutation) to design peptides and peptide mixtures for development as therapeutics, diagnostic kits, and as reagents for antibody generation. The Company is building a unique suite of expertise in the manufacture and control of peptide copolymer-based drug products.
18
| Extinct | Biotechnology | 18 |
Cleveland Diagnostics, Inc.
 Cleveland Diagnostics, Inc. Investment Trusts/Mutual FundsMiscellaneous Cleveland Diagnostics, Inc. develops and commercializes cancer diagnostics and screening tests. Its portfolio of non-invasive cancer diagnostic tests includes blood-based tests to screen for prostate, breast, and ovarian cancer. The company was founded by Arnon Chait and Boris Zaslavsky in October 2013 and is headquartered in Cleveland, OH.
8
| Holding Company | Investment Trusts/Mutual Funds | 8 |
Helio Vision, Inc.
 Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
| Holding Company | Biotechnology | 7 | |
Access BridgeGap Ventures
 Access BridgeGap Ventures Investment ManagersFinance Founded in 2011, Access BridgeGap Ventures is a venture capital firm located in Cambridge, Massachusetts. The firm is the life sciences venture capital investment arm of Access Industries, Inc.
6
| Extinct | Investment Managers | 6 |
Zero Stage Capital Co., Inc.
 Zero Stage Capital Co., Inc. Investment ManagersFinance Founded in 1981, Zero Stage Capital Co., Inc. is a venture capital firm headquartered in Cambridge, Massachusetts.
5
| Extinct | Investment Managers | 5 |
| Public Company | Medical/Nursing Services | 5 | |
Sentien Biotechnologies, Inc.
 Sentien Biotechnologies, Inc. BiotechnologyHealth Technology Sentien Biotechnologies, Inc. develops cell-based therapy for critical care. It provides the Sentinel, a device that actively treats patients during a dialysis dose by supplementing patient blood with MSC-derived secretions. The company was founded by Brian Miller and Biju Parekkadan and is headquartered in Lexington, MA.
1
| Holding Company | Biotechnology | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ben Bronstein via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Biotechnology | President Chief Executive Officer | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| The University of Chicago | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| COLUCID PHARMACEUTICALS INC | Biotechnology | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Chairman General Counsel Chairman | |
NovaDigm Therapeutics, Inc.
 NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
eXIthera Pharmaceuticals, Inc.
 eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| University of Tennessee | College/University | Undergraduate Degree Doctorate Degree Masters Business Admin | |
Allievex Corp.
 Allievex Corp. Pharmaceuticals: OtherHealth Technology Allievex Corp. operates as a biotechnology company. It develops therapies for the treatment of rare pediatric neurodegenerative diseases. The company was founded by Thomas P. Mathers and Eric H. Zanelli and is headquartered in Marblehead, MA. | Pharmaceuticals: Other | Founder Founder | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Integrated Genetics, Inc.
 Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| US Military Academy | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Corporate Officer/Principal Undergraduate Degree | |
| New York University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Clark University | College/University | Undergraduate Degree Undergraduate Degree | |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor Private Equity Investor | |
Stealth BioTherapeutics, Inc.
 Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| University of California San Diego | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Cardion GmbH
 Cardion GmbH Medical SpecialtiesHealth Technology Cardion GmbH develops biopharmaceutical products. It integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products. The company is headquartered in Dusseldorf, Germany. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| Georgia Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Corporate Officer/Principal | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Michigan | College/University | Undergraduate Degree Graduate Degree | |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Graduate Degree Graduate Degree | |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | Director/Board Member General Counsel |
Statistiques
Internationale
| Etats-Unis | 47 |
| Royaume-Uni | 2 |
| Allemagne | 2 |
Sectorielle
| Health Technology | 30 |
| Consumer Services | 15 |
| Commercial Services | 4 |
| Finance | 3 |
Opérationnelle
| Director/Board Member | 310 |
| Corporate Officer/Principal | 176 |
| Chairman | 67 |
| Independent Dir/Board Member | 66 |
| Founder | 60 |
Relations les plus connectées
| Insiders | |
|---|---|
| Michael Barrett | 49 |
| Luke Evnin | 42 |
| Jesse I. Treu | 38 |
| Asish Xavier | 33 |
| Neal Walker | 24 |
| Jose-Carlos Gutiérrez-Ramos | 24 |
| Steven Hyman | 21 |
| David J. Clark | 21 |
| Isaac Kohlberg | 20 |
| Todd Brady | 20 |
| Arthur Anton | 20 |
| Gary Phillips | 20 |
| Daniel Behr | 20 |
| Robert Carpenter | 19 |
| Thomas Mathers | 19 |
- Bourse
- Insiders
- Ben Bronstein
- Connexions Sociétés